Life Wellness Healthcare has updated its product range to restock the AirPhysio OPEP device due to popular demand. The wellness company explains that the product is suitable for 99% of those with ...

The global COPD and asthma devices market size reached US$ 40.82 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 57.09 Billion by 2027, exhibiting a CAGR of 5.75% ...

A handheld portable device achieves similar results to conventional oscillometry when testing resistance parameters in patients with chronic obstructive pulmonary disease (COPD), a new study found ...

Actually, the device described is more a "lung sax" than a "lung flute". It has a vibrating reed. A flute doesn't; its "reed" is merely a hole with a sharpened edge, which doesn't itself vibrate.

Built as an open source project, “Flutter for Tizen” is able to run applications on Galaxy Watches running Tizen 4.0 or newer, Samsung Smart TVs running Tizen 6.0 or newer, and IoT devices.

The N-Tidal device test takes under five minutes from breath to result Oxford clinicians will be the first to use a new AI-driven device for assessing chronic obstructive pulmonary disease (COPD ...

This patient had classic atrial flutter with a cycle length of 240 msec prior to ablation. The P waves were deeply negative in ECG leads II, III, and aVF, and were initially upright in V1. Note ...

Mucus clearance devices are viewed as therapeutically essential for the treatment of asthma, bronchiectasis, cystic fibrosis, and COPD. Increment in the number of solicitations regarding traveling ...

A U.S. advisory panel backed an experimental CryoCor Inc. <CRYO.O> device to treat a type of abnormal heart rhythm, a Food and Drug Administration spokeswoman said on Wednesday.

A 64-year-old male presents 2 weeks following successful atrial flutter ablation and dual-chamber pacemaker implantation complaining of fatigue, but had no palpitations. What is the diagnosis?